Clinical trial

Body Composition and Adipose Tissue in HIV

NCT03226821

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2018-02-07

PhasePHASE4

Study timeline

Study start (actual)2018-02-07Date precision: day

Registry last updated2026-05-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Lipodystrophy Syndromeunresolved

Growth Hormone Deficiencyunresolved

Body Compositionunresolved

Interventions

TesamorelinDRUG

Sponsors & collaborators

Columbia Universitylead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03226821 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.